Showing 441-450 of 4673 results for "".
Ask an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Skin Cancer Prevention: Can Laser Therapy Help?
https://practicaldermatology.com/conferences/scale-2023/skin-cancer-prevention-can-laser-therapy-help/20205/Non-ablative fractional laser treatments may dramatically the reduce risk of skin cancer recurrence. Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss the science behind this intriguing finding.First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.Noah Worcester 2024: Dr. Jogi on Hair Loss
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-jogi-hair-loss/24590/Joel L. Cohen, MD, FAAD, interviews Reena Jogi, MD about her lecture on hair loss and platelet-rich plasma at the 2024 Noah Worcester Dermatological Society meeting.Aloha Maui Derm
https://practicaldermatology.com/topics/psoriasis/aloha-maui-derm/19715/What is the magic that makes Maui Derm so special? Joel Cohen, MD and meeting founder and director George Martin, MD, go behind the scenes of one of the most popular meetings in dermatology.What's New in Dermatopathology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/what-s-new-in-dermatopathology/18992/Joshua Zeichner, MD speaks with Clay Cockerell, MD about the latest developments in dermatopathology. Specifically, Dr. Cockerell discusses how new tests may change melanoma diagnosis and change the way dermatopathologists and dermatologists interact.Update on Melanoma Detection and Screening
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-melanoma-detection-and-screening/19095/From full body skin exams to emerging tape-strip methods for melanoma diagnosis, Laura Ferris, MD talks about the latest research in skin cancer diagnosis with host Joshua Zeichner, MD.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.Opportunities and Barriers in Teledermatology
https://practicaldermatology.com/conferences/aad-2021/opportunities-and-barriers-in-teledermatology/19923/Dermatologists' participation in telemedicine has increased exponentially over the past year. But what does the future hold? What opportunities exist and what challenges remain? Jules Lipoff, MD weighs in.